A single dose of the recombinant respiratory syncytial virus (RSV) vaccine demonstrates effectiveness against infections and associated hospitalizations in veterans aged 60 years or older during ...

Antibody responses to the O-specific polysaccharide of Klebsiella pneumoniae were immunogenic, with cross-reactivity among related subtypes; however, capsule interference with O-specific ...